Literature DB >> 24452755

Recurrence of left ventricular dysfunction in patients with restored idiopathic dilated cardiomyopathy.

Jin-Sun Park1, Jin-Woo Kim, Kyoung-Woo Seo, Byoung-Joo Choi, So-Yeon Choi, Myeong-Ho Yoon, Gyo-Seung Hwang, Seung-Jea Tahk, Joon-Han Shin.   

Abstract

BACKGROUND: In some patients with nonischemic idiopathic dilated cardiomyopathy (DCM), left ventricular (LV) dysfunction improves spontaneously but can recur. The factors predicting recurrence of LV dysfunction in recovered idiopathic DCM are poorly defined. We investigated the clinical, echocardiographic, and laboratory variables affecting recurrence of LV dysfunction in patients who recovered from DCM. HYPOTHESIS: The recurrence of LV dysfunction in recovered idiopathic DCM is impacted by clinical, echocardiographic, and laboratory variables.
METHODS: The study comprised 85 consecutively enrolled patients (62 males, age 57 ± 16 years) with DCM who achieved a restoration of LV systolic function. Patients were followed up for 50 ± 33 months after recovery from LV dysfunction without discontinuation of standard medication for heart failure with depressed ejection fraction. Clinical, echocardiographic, and laboratory variables were analyzed to identify factors independently associated with recurrence of LV dysfunction.
RESULTS: LV dysfunction recurred in 33 patients (23 males, age 64 ± 12 years). Univariate analysis revealed that age, duration from initial presentation to recovery time, diabetes, and LV end-diastolic dimension (LVEDD) at initial presentation were associated with recurrence of LV dysfunction. Multivariate analysis revealed that only age, diabetes, and LVEDD at initial presentation were independent predictors in patients who recovered from LV dysfunction.
CONCLUSIONS: The recurrence of LV dysfunction was significantly correlated with age, presence of diabetes, and LVEDD at initial presentation. Clinicians should consider maintenance of intensive care to patients who recovered from DCM with these factors.
© 2014 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2014        PMID: 24452755      PMCID: PMC6649465          DOI: 10.1002/clc.22243

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  8 in total

Review 1.  Epidemiology of "Heart Failure with Recovered Ejection Fraction": What do we do After Recovery?

Authors:  Johny S Kuttab; Michael S Kiernan; Amanda R Vest
Journal:  Curr Heart Fail Rep       Date:  2015-12

2.  Rationale and Study Design of the Withdrawal of Spironolactone for Heart Failure with Improved Left Ventricular Ejection Fraction.

Authors:  Junho Hyun; Sang Eun Lee; Seung-Ah Lee; Jung Ae Hong; Min-Seok Kim; Jae-Joong Kim
Journal:  Int J Heart Fail       Date:  2021-01-14

3.  Very long-term follow-up data of non-ischemic idiopathic dilated cardiomyopathy after beta-blocker therapy: recurrence of left ventricular dysfunction and predictive value of 123I-metaiodobenzylguanidine scintigraphy.

Authors:  Shunsuke Nishimura; Chisato Izumi; Yoshihiro Himura; Maiko Kuroda; Masashi Amano; Takeshi Harita; Suguru Nishiuchi; Jiro Sakamoto; Yodo Tamaki; Soichiro Enomoto; Makoto Miyake; Toshihiro Tamura; Hirokazu Kondo; Yoshihisa Nakagawa
Journal:  Heart Vessels       Date:  2018-08-24       Impact factor: 2.037

4.  Prevalence and Prognosis of HFimpEF Developed From Patients With Heart Failure With Reduced Ejection Fraction: Systematic Review and Meta-Analysis.

Authors:  Yibo He; Yihang Ling; Wei Guo; Qiang Li; Sijia Yu; Haozhang Huang; Rongting Zhang; Zhiwen Gong; Jiaxuan Liu; Liyi Mo; Shixin Yi; Disheng Lai; Younan Yao; Jin Liu; Jiyan Chen; Yong Liu; Shiqun Chen
Journal:  Front Cardiovasc Med       Date:  2021-11-25

5.  Development and Validation of a Novel Nomogram to Predict Improved Left Ventricular Ejection Fraction in Patients With Heart Failure After Successful Percutaneous Coronary Intervention for Chronic Total Occlusion.

Authors:  Lulu Yang; Huan Li; Guangli Guo; Jiaqi Du; Zhengyang Hao; Lingyao Kong; Huiting Shi; Xiaofang Wang; Yanzhou Zhang
Journal:  Front Cardiovasc Med       Date:  2022-04-14

Review 6.  Myocardial remodelling and recovery in dilated cardiomyopathy.

Authors:  Upasana Tayal; Sanjay K Prasad
Journal:  JRSM Cardiovasc Dis       Date:  2017-10-09

7.  Late gadolinium enhancement for re-worsening left ventricular ejection fraction in patients with dilated cardiomyopathy.

Authors:  Takeru Nabeta; Shunsuke Ishii; Yuki Ikeda; Kenji Maemura; Takumi Oki; Mayu Yazaki; Teppei Fujita; Takashi Naruke; Takayuki Inomata; Junya Ako
Journal:  ESC Heart Fail       Date:  2020-12-03

Review 8.  Heart failure with recovered ejection fraction and the utility of defibrillator therapy: a review.

Authors:  Jasneet K Devgun; Samuel Kennedy; Jeremy Slivnick; Zachary Garrett; Katherine Dodd; Mohamed H Derbala; Cristina Ortiz; Sakima A Smith
Journal:  ESC Heart Fail       Date:  2021-12-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.